Introduction

From March 19–22, 2026, Dr.Pen, together with Byall Medical, exhibited at KIMES 2026 (Korea International Medical & Hospital Equipment Show) held at COEX, Seoul. At Booth BL600, the brand presented its full product portfolio and latest technological innovations in microneedling, attracting strong attention from international industry professionals, distributors, and clients.

KIMES 2026 — Strength on Display, Recognition Earned

01. Strong On-Site Presence and Professional Engagement

At KIMES 2026, the Dr.Pen booth stood out with a clean, modern design and high-tech product presentation, becoming a key focal point for visitors throughout the exhibition.

The team maintained continuous on-site engagement with global clients, delivering structured consultations and live demonstrations. Key discussion areas included product performance, operational procedures, and real-world clinical applications.

Visitors gained a clear and direct understanding of the product advantages in:

• Safety and stability
• Precision control
• Ease of operation

Overall, the booth received consistent positive feedback and strong professional interest.

02. Comprehensive Product Portfolio for Diverse Applications

At the exhibition, Byall Medical showcased a complete ecosystem of microneedling solutions, including Dr.Pen, Hydra.Pen, Bio.Pen, and other core device series.

This diversified portfolio covers a full range of needs, from entry-level applications to more advanced professional treatments, forming a structured and scalable product system.

During the event, many international visitors actively engaged with the devices, initiating discussions on product usage and potential cooperation.

This strong market response further confirmed:

• Dr.Pen’s technological leadership in microneedling
• Its strong recognition across international markets
• Its established credibility within the professional aesthetics industry

03. Global Expansion and Industry Positioning

As one of Asia’s most influential medical device exhibitions, KIMES serves as a key platform for industry exchange and international visibility.

By participating with its full product range, Dr.Pen further strengthened its global brand presence and deepened communication with international partners. The exhibition also provided valuable insights into evolving market demands and future product optimization directions.

The overall outcome reinforced a clear strategic direction: continuous innovation driven by technology, combined with sustained global market expansion.

Closing Note

We sincerely thank all partners and visitors who visited Booth BL600 at KIMES 2026.

Every conversation contributed to meaningful exchange and long-term trust-building.

Dr.Pen will continue to advance its innovation in microneedling technology and expand its global footprint, delivering safer, more efficient, and more professional solutions to the international market.